A combination of an NPY1R agonist and Ketamine, given together to rodents, produced stronger antidepressant-like effects than either drug alone. The animals showed less immobility in a forced swimming test, a standard measure of antidepressant activity. This behavioral change was linked to increased formation of NPY1R/TrkB receptor complexes and higher levels of brain-derived neurotrophic factor (BDNF) in the ventral dentate gyrus of the hippocampus, along with increased neurogenesis. The results suggest that co-activating NPY1R and TrkB pathways may represent a novel therapeutic strategy for major depressive disorder that warrants further clinical investigation.
MDMA, known for promoting prosocial feelings in humans, unexpectedly reduced social behavior in male rats regardless of whether they lived alone or in groups. In female rats, the same reduction occurred only in those housed individually; group-housed females showed no change. The data also hinted that individual rats varied in their response to MDMA, suggesting personal differences matter. More research is needed to understand how such variation influences MDMA's effects.